TABLE. Adaptations of the national human immunodeficiency virus (HIV) testing and treatment program during the COVID-19 outbreak — Namibia, 2020.
Program area | Program adaptations |
---|---|
Clinic readiness
|
Screening and triaging clients for COVID-19 symptoms |
Adjusting clinic flow to limit overcrowding and exposure risk for patients and health care workers | |
Limiting clinic appointments to avoid crowding (prioritizing patients failing ART or clinical complaints) | |
Providing ART refills without entering the facility | |
Providing expedited services for patients at higher risk for COVID-19 morbidity and mortality | |
Using Project ECHO platform for regular communication, coordination and telementoring for all regions | |
Providing virtual COVID-19 trainings for staff members | |
Providing PPE | |
MMD of ART (adults, children, and pregnant and breastfeeding women)
|
Assessing national stock situation and adjusting ART guidance to ensure adequate medication stock for MMD |
Issuing and widely sharing interim ART guidance through ECHO and clinical mentorship network | |
Distributing stock to regions to ensure adequate supplies for MMD | |
Community dispensing
|
Using community-based ART outreach points |
Adapting and expanding community adherence groups with groups <10 at one time | |
Expanding primary health care outreach points | |
Using mobile vans (especially for persons at high risk and for those unable to get MMD) | |
Establishing home delivery (through community health care workers) | |
Patient tracing
|
Shifting physical tracing of patients missing appointments to phone tracing exclusively |
Strengthening border services
|
Liaising with regional governments, immigration authorities, and police to allow patients to access medicines |
Creating outreach points for patients to access ART at the Angola-Namibia border | |
Tracing patients who miss appointments via telephone to link them back into care | |
Establishing ART hotline to assist patients having difficulty accessing services and answer questions about COVID-19 and HIV | |
Facility HIV testing
|
Prioritizing facility-based testing (antenatal care, admitted patients, early infant diagnosis, persons with tuberculosis and sexually transmitted infections, passive index testing) |
Standardizing safe HIV testing services provision using physical distancing and PPE measures | |
Maximizing use of self-testing kits* outside of clinic settings for clients and their partners | |
Community index testing
|
Discontinuing community index testing until safe processes were established |
Providing guidance for proper PPE use to implement community index testing once deemed safe | |
HIV recency testing
|
Pausing recency testing to decrease time spent in clinics and decrease burden on laboratory staff members |
Community adolescent treatment supporters and teen clubs
|
Providing community adolescent treatment supporters with mobile phones and airtime to continue to engage beneficiaries from home |
Limiting teen clubs to continue meeting in only places where they could practice recommended physical distancing with no more than 10 teens at a time | |
Cervical cancer screening and treatment
|
Continuing limited screening at health facilities that have program-specific staff members |
Postponing all outreach and campaigns | |
Tuberculosis preventive therapy
|
Dispensing tuberculosis preventive therapy for the full duration of treatment for those initiating or already receiving tuberculosis preventive therapy |
Delivering tuberculosis preventive therapy medications to eligible clients through community health care workers with recommended PPE and physical distancing | |
Prevention of mother-to-child transmission of HIV | Continuing routine testing of pregnant and breastfeeding women and HIV-exposed infants |
Providing MMD for pregnant and breastfeeding women | |
Prioritizing safe labor and delivery access in health care facilities with adjustments in clinic flow to minimize the risk for COVID-19 exposure | |
Providing pregnant and breastfeeding women adherence and retention support through telephone calls |
Abbreviations: ART = antiretroviral therapy; COVID-19 = coronavirus disease 2019; MMD = multimonth dispensing; PPE = personal protective equipment; Project ECHO = Extension for Community Healthcare Outcomes.
* OraSure Technologies. http://www.oraquick.com.